Mice lacking NMDA receptors in parvalbumin neurons display normal depression-related behavior and response to antidepressant action of NMDAR antagonists.
The underlying circuit imbalance in major depression remains unknown and current therapies remain inadequate for a large group of patients. Discovery of the rapid antidepressant effects of ketamine--an NMDA receptor (NMDAR) antagonist--has linked the glutamatergic system to depression. Interestingly...
Guardado en:
Autores principales: | Laura Pozzi, Iskra Pollak Dorocic, Xinming Wang, Marie Carlén, Konstantinos Meletis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/91e29715fbfb458c85e4b3c44a6419c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: NMDA-receptor inhibition and oxidative stress during hippocampal maturation differentially alter parvalbumin expression and gamma-band activity
por: Luisa A. Hasam-Henderson, et al.
Publicado: (2018) -
The role of NMDAR antibody in the etiopathogenesis of schizophrenia
por: Timucin D, et al.
Publicado: (2016) -
Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems.
por: Soheil Keihan Falsafi, et al.
Publicado: (2012) -
A peculiar case of psychosis: anti-NMDAr encephalitis
por: Lamia Kouba, et al.
Publicado: (2021) -
Transgenic mice lacking CREB and CREM in noradrenergic and serotonergic neurons respond differently to common antidepressants on tail suspension test
por: Katarzyna Rafa–Zabłocka, et al.
Publicado: (2017)